13058_2018_1067_MOESM3_ESM.xlsx (14.44 kB)
Additional file 3: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
dataset
posted on 2018-11-20, 05:00 authored by Marcus Vetter, Julia Landin, Barbara Szczerba, Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, Ilona Krol, Ramona Scherrer, Catharina Balmelli, Alexandra Malinovska, Alfred Zippelius, Christian Kurzeder, Viola Heinzelmann-Schwarz, Walter Weber, Christoph Rochlitz, Nicola AcetoTable S3. Patient characteristics. The table shows the characteristics of the 73 patients included in the study. Abbreviations: ER Estrogen receptor, HER2 Human epidermal growth factor receptor 2, ID Invasive ductal, IL Invasive lobular, NA Not available, PR Progesterone receptor, ECOG Eastern Cooperative Oncology Group (as defined by Oken et al. [24]). (XLSX 14 kb)
